3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
25
INDUSTRY
8
NIH
3
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Recurrent Squamous Cell Lung Carcinoma
2
Prostatic Neoplasms
2
Colorectal Neoplasms
2
Squamous Non-small Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Malignancies
1
Neoplasms
1
Lung Cancer Metastatic
1
Colorectal Cancer Metastatic
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Advanced Rare Tumours
1
Interventions
Fluorouracil
2
tremelimumab
1
motexafin gadolinium
1
lenvatinib
1
ispinesib
1
durvalumab
1
X-Rays
1
Specimen Handling
1
Sorafenib
1
Radiotherapy
1
Radiosurgery
1
Radiofrequency Ablation
1
Platinum
1
Phantoms, Imaging
1
Ondansetron
1
Mitomycin
1
Interferon-alpha
1
Gemcitabine
1
Embolization, Therapeutic
1
Doxorubicin
1
Dexamethasone
1
Cisplatin
1
Capecitabine
1
CF regimen
1
Bone Density
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Carcinoma, Hepatocellular
×
tremelimumab
×
Clear all
NCT06880523
2026-04-14
SLIDE-HCC
Canadian Cancer Trials Group
Phase 2
Recruiting
140 enrolled